HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.

AbstractBACKGROUND:
Chemoresistance and advanced tumour stage at time of diagnosis are the major reasons for poor treatment results in hepatoblastoma (HB) and paediatric hepatocellular carcinoma (HCC). Positive results with transplantation of liver and bone marrow revealed the impact of the immune system on the treatment of liver malignancies.
AIM:
Cytotoxic-immune-cells-like natural killer (NK) and T cells are major player in the defence against developing tumours. This study aimed to specifically analyse the ability of ex-vivo expanded γδ T cells to recognise and lyse HB and HCC cell lines in coculture assays.
METHODS:
Cell viability after treatment with γδ T cells was evaluated with two HB (HUH6 and HepT1) and one HCC cell line (HC-AFW1) using a MTT-based cytotoxicity assay. The binding of T cells to target cells was monitored using immunofluorescence microscopy.
RESULTS:
Incubation of hepatic tumour cell lines with γδ T cells led to a significant decrease in tumour cell viability. This was enhanced by zoledronic acid and histone deacetylase inhibitors. MT110, an EpCAM/CD3-bispecific BiTE antibody could bluntly enhance tumour cell lysis close to completion. γδ T cells efficiently interacted with HB and HCC cells in a spheroid culture model.
CONCLUSION:
Bispecific antibodies such as MT110 might be used to intensify the antitumoural effect of γδ T cells in context of adoptive immune cell transfer. Optimised immunotherapeutic strategies might therefore improve the outcome of high risk hepatoblastoma and hepatocellular carcinoma.
AuthorsAlexander Hoh, Alexander Dewerth, Fabian Vogt, Julia Wenz, Patrick A Baeuerle, Steven W Warmann, Joerg Fuchs, Sorin Armeanu-Ebinger
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 33 Issue 1 Pg. 127-36 (Jan 2013) ISSN: 1478-3231 [Electronic] United States
PMID23088518 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 John Wiley & Sons A/S.
Chemical References
  • Antibodies, Bispecific
  • Antigens, Neoplasm
  • CD3 Complex
  • Cell Adhesion Molecules
  • Diphosphonates
  • EPCAM protein, human
  • Epithelial Cell Adhesion Molecule
  • Histone Deacetylase Inhibitors
  • Imidazoles
  • MT110 monoclonal antibody
  • Receptors, Antigen, T-Cell, gamma-delta
  • Single-Chain Antibodies
  • Zoledronic Acid
Topics
  • Antibodies, Bispecific (pharmacology)
  • Antigens, Neoplasm (immunology)
  • CD3 Complex (immunology)
  • Carcinoma, Hepatocellular (immunology, pathology)
  • Cell Adhesion Molecules (immunology)
  • Cell Line, Tumor
  • Cell Survival
  • Coculture Techniques
  • Cytotoxicity, Immunologic (drug effects)
  • Diphosphonates (pharmacology)
  • Epithelial Cell Adhesion Molecule
  • Hepatoblastoma (immunology, pathology)
  • Histone Deacetylase Inhibitors (pharmacology)
  • Humans
  • Imidazoles (pharmacology)
  • Liver Neoplasms (immunology, pathology)
  • Lymphocyte Activation (drug effects)
  • Microscopy, Fluorescence
  • Receptors, Antigen, T-Cell, gamma-delta (immunology)
  • Single-Chain Antibodies (pharmacology)
  • Spheroids, Cellular
  • T-Lymphocytes (drug effects, immunology)
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: